Logo image of LLNW

Limelight Networks Inc (LLNW) Stock Fundamental Analysis

NASDAQ:LLNW - Nasdaq - US53261M1045 - Common Stock

2.46  +0.04 (+1.65%)

After market: 2.46 0 (0%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to LLNW. LLNW was compared to 82 industry peers in the IT Services industry. LLNW has a bad profitability rating. Also its financial health evaluation is rather negative. LLNW is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

LLNW had negative earnings in the past year.
LLNW Yearly Net Income VS EBIT VS OCF VS FCFLLNW Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 0 20M -20M -40M -60M

1.2 Ratios

Industry RankSector Rank
ROA -15.72%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
LLNW Yearly ROA, ROE, ROICLLNW Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 0 -10 -20 -30 -40 -50

1.3 Margins

Industry RankSector Rank
OM -11.47%
PM (TTM) -21.57%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
LLNW Yearly Profit, Operating, Gross MarginsLLNW Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 0 20 -20 40 -40

More info and screens

2

2. Health

2.1 Basic Checks

LLNW does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, LLNW has more shares outstanding
The debt/assets ratio for LLNW is higher compared to a year ago.
LLNW Yearly Shares OutstandingLLNW Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 20M 40M 60M 80M 100M
LLNW Yearly Total Debt VS Total AssetsLLNW Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 100M 200M 300M

2.2 Solvency

LLNW has an Altman-Z score of -0.21. This is a bad value and indicates that LLNW is not financially healthy and even has some risk of bankruptcy.
LLNW has a Debt/Equity ratio of 0.90. This is a neutral value indicating LLNW is somewhat dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.9
Debt/FCF N/A
Altman-Z -0.21
ROIC/WACCN/A
WACC6.89%
LLNW Yearly LT Debt VS Equity VS FCFLLNW Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 0 50M 100M 150M

2.3 Liquidity

A Current Ratio of 3.31 indicates that LLNW has no problem at all paying its short term obligations.
A Quick Ratio of 3.31 indicates that LLNW has no problem at all paying its short term obligations.
Industry RankSector Rank
Current Ratio 3.31
Quick Ratio 3.31
LLNW Yearly Current Assets VS Current LiabilitesLLNW Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 50M 100M 150M

More info and screens

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 10.00% over the past year.
Looking at the last year, LLNW shows a small growth in Revenue. The Revenue has grown by 0.00% in the last year.
Measured over the past years, LLNW shows a small growth in Revenue. The Revenue has been growing by 5.29% on average per year.
EPS 1Y (TTM)10%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%55.56%
Revenue 1Y (TTM)0%
Revenue growth 3Y3.6%
Revenue growth 5Y5.29%
Sales Q2Q%13.2%

3.2 Future

LLNW is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 47.20% yearly.
The Revenue is expected to grow by 9.24% on average over the next years. This is quite good.
EPS Next Y81.79%
EPS Next 2Y47.31%
EPS Next 3Y40.97%
EPS Next 5Y47.2%
Revenue Next Year12.93%
Revenue Next 2Y11.04%
Revenue Next 3Y10.21%
Revenue Next 5Y9.24%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
LLNW Yearly Revenue VS EstimatesLLNW Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 100M 200M 300M
LLNW Yearly EPS VS EstimatesLLNW Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 0.2 0.4 0.6

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for LLNW. In the last year negative earnings were reported.
A Price/Forward Earnings ratio of 103.38 indicates a quite expensive valuation of LLNW.
LLNW is valuated expensively when we compare the Price/Forward Earnings ratio to 36.28, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 103.38
LLNW Price Earnings VS Forward Price EarningsLLNW Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 60 80 100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -740.75
LLNW Per share dataLLNW EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5

4.3 Compensation for Growth

LLNW's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
LLNW's earnings are expected to grow with 40.97% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y47.31%
EPS Next 3Y40.97%

More info and screens

0

5. Dividend

5.1 Amount

LLNW does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Limelight Networks Inc

NASDAQ:LLNW (6/15/2022, 8:18:23 PM)

After market: 2.46 0 (0%)

2.46

+0.04 (+1.65%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)04-28 2022-04-28/bmo
Earnings (Next)07-27 2022-07-27
Inst Owners0.04%
Inst Owner Change0%
Ins Owners8.56%
Ins Owner Change0%
Market Cap339.95M
Analysts82.86
Price Target6.34 (157.72%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 103.38
P/S 1.51
P/FCF N/A
P/OCF N/A
P/B 2.51
P/tB N/A
EV/EBITDA -740.75
EPS(TTM)-0.09
EYN/A
EPS(NY)0.02
Fwd EY0.97%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS1.62
BVpS0.98
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -15.72%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM -11.47%
PM (TTM) -21.57%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y1%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.73
Health
Industry RankSector Rank
Debt/Equity 0.9
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.31
Quick Ratio 3.31
Altman-Z -0.21
F-Score2
WACC6.89%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)10%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%55.56%
EPS Next Y81.79%
EPS Next 2Y47.31%
EPS Next 3Y40.97%
EPS Next 5Y47.2%
Revenue 1Y (TTM)0%
Revenue growth 3Y3.6%
Revenue growth 5Y5.29%
Sales Q2Q%13.2%
Revenue Next Year12.93%
Revenue Next 2Y11.04%
Revenue Next 3Y10.21%
Revenue Next 5Y9.24%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A